Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

Pfizer, Catholic University Leuven deal

September 27, 2010 7:00 AM UTC

The university granted Pfizer exclusive, worldwide rights to develop and commercialize ledgins to treat HIV infection. Ledgins are compounds which inhibit the interaction between viral integrase and t...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article